摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-乙氧基-2-苯基-1,3-恶唑-4-羧酸 | 54644-12-1

中文名称
5-乙氧基-2-苯基-1,3-恶唑-4-羧酸
中文别名
——
英文名称
5-ethoxy-2-phenyloxazole-4-carboxylic acid
英文别名
4-Carboxy-5-ethoxy-2-phenyloxazole;5-ethoxy-2-phenyl-oxazole-4-carboxylic acid;5-Aethoxy-2-phenyl-oxazol-4-carbonsaeure;5-ethoxy-2-phenyl-1,3-oxazole-4-carboxylic Acid
5-乙氧基-2-苯基-1,3-恶唑-4-羧酸化学式
CAS
54644-12-1
化学式
C12H11NO4
mdl
MFCD08691172
分子量
233.224
InChiKey
FKTHAJTWXRSXRZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    72.6
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2934999090

SDS

SDS:2cc2261780ae915e7c22c8b71b5773bf
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • SPIRO-CYCLIC COMPOUND
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP1911753A1
    公开(公告)日:2008-04-16
    The present invention provides a compound represented by the formula (I): wherein E is an optionally substituted cyclic group; D is a carbonyl group or a sulfonyl group; A is CH or N; ring P is an optionally further substituted 5- to 7-membered ring; ring Q is an optionally further substituted 5- to 7-membered nonaromatic ring; and ring R is an optionally further substituted and optionally condensed 5- to 7-membered nonaromatic ring, or a salt thereof. The compound of the present invention has an ACC inhibitory activity, is useful for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia and the like, and has superior properties in the efficacy, duration of activity, specificity, low toxicity and the like.
    本发明提供了一种由以下式(I)表示的化合物: 其中 E是一个可选择地取代的环状基团; D是一个羰基团或磺酰基团; A是CH或N; 环P是一个可选择进一步取代的5至7元环; 环Q是一个可选择进一步取代的5至7元非芳香环; 环R是一个可选择进一步取代和可选择缩合的5至7元非芳香环,或其盐。本发明的化合物具有ACC抑制活性,对于肥胖、糖尿病、高血压、高脂血症、心力衰竭、糖尿病并发症、代谢综合征、肌肉萎缩等的预防或治疗具有用处,并且在功效、持续活性、特异性、低毒性等方面具有优越性能。
  • Structure–activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors
    作者:Isak Im、Eui Seung Lee、Soo Jeong Choi、Ju-Yeon Lee、Yong-Chul Kim
    DOI:10.1016/j.bmcl.2009.04.114
    日期:2009.7
    Human rhinovirus 3C protease (HRV 3C(pro)) is known to be a promising target for development of therapeutic agents against the common cold because of the importance of the protease in viral replication as well as its expression in a large number of serotypes. To explore non-peptidic inhibitors of HRV 3C(pro), a series of novel heteroaromatic esters was synthesized and evaluated for inhibitory activity against HRV 3C(pro), to determine the structure-activity relationships. The most potent inhibitor, 7, with a 5-bromopyridinyl group, had an IC50 value of 80 nM. In addition, the binding mode of a novel analog, 19, with the 4-hydroxyquinolinone moiety, was explored by molecular docking, suggesting a new interaction in the S1 pocket. (C) 2009 Elsevier Ltd. All rights reserved.
  • A New Synthesis of Oxazolo[5,4-<i>d</i>]pyrimid-7-ones
    作者:Ignatius J. Turchi、Cynthia A. Maryanoff
    DOI:10.1055/s-1983-30535
    日期:——
  • Scope and limitations of the Cornforth rearrangement
    作者:Michael J. S. Dewar、Ignatius J. Turchi
    DOI:10.1021/jo00898a040
    日期:1975.5
  • CORRAO, STEPHANIE L.;MACIELAG, MARK J.;TURCHI, IGNATIUS J., J. ORG. CHEM., 55,(1990) N4, C. 4484-4487
    作者:CORRAO, STEPHANIE L.、MACIELAG, MARK J.、TURCHI, IGNATIUS J.
    DOI:——
    日期:——
查看更多